MNOV

NASDAQ 已收盘

MediciNova

1.31 USD
▲+0.04+3.15%
盘后 1.39 0.00%
2026-11-20
市值
$67.11M
市盈率
—
EPS
-0.21
股息率
—
52 周区间
1.22 – 3.90
成交量
48.96K
Beta
0.71
目标价
8.25
52W 低 1.2252W 高 3.90
价格走势

公司简介

MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. It develops MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent in Phase 2 clinical trial for treating neurological and other disorders, such as progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, and glioblastoma, as well as prevention of acute res...